Savior Lifetec (ROCO:4167) Total Liabilities: NT$403 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4167 Savior Lifetec Corp ROCO:4167
68 GF Score
Price NT$21.30
GF Value NT$20.31
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Savior Lifetec Total Liabilities?

Savior Lifetec ROCO:4167 +3.40% 68 Total Liabilities is NT$403 Mil as of Dec. 2025. GuruFocus rates ROCO:4167 with a GF Score™ of 68/100 and a GF Value™ of NT$20.31 (Fairly Valued). The stock has 3 warning signs investors should review.

Savior Lifetec's Total Liabilities for the quarter that ended in Dec. 2025 was NT$403 Mil.

Savior Lifetec's quarterly Total Liabilities declined from Jun. 2025 (NT$479.79 Mil) to Sep. 2025 (NT$420.16 Mil) and declined from Sep. 2025 (NT$420.16 Mil) to Dec. 2025 (NT$403.30 Mil).

Savior Lifetec's annual Total Liabilities increased from Dec. 2023 (NT$457.96 Mil) to Dec. 2024 (NT$860.02 Mil) but then declined from Dec. 2024 (NT$860.02 Mil) to Dec. 2025 (NT$403.30 Mil).

Savior Lifetec Total Liabilities Historical Data

* Premium members only.

The historical data trend for Savior Lifetec's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Savior Lifetec Total Liabilities Chart

Savior Lifetec Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,225.86 1,041.82 457.96 860.02 403.30

Savior Lifetec Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 860.02 342.16 479.79 420.16 403.30
ROCO:4167
68GF Score
Savior Lifetec Corp ROCO:4167
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Savior Lifetec Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Savior Lifetec's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=231.194+(172.108+2.8421709430404E-14
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=403

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=4184.112-3780.81
=403

Savior Lifetec's Total Liabilities for the quarter that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=231.194+(172.108+2.8421709430404E-14
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=403

Total Liabilities=Total Assets (Q: Dec. 2025 )-Total Equity (Q: Dec. 2025 )
=4184.112-3780.81
=403

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of NT$403 Mil mean?
Savior Lifetec (ROCO:4167) has a Total Liabilities of NT$403 Mil as of Dec. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Savior Lifetec and its competitors.
Is Savior Lifetec's Total Liabilities too high?
Savior Lifetec's current Total Liabilities is NT$403 Mil. Overall, Savior Lifetec has a GF Score™ of 68/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Savior Lifetec's Total Liabilities compare to VRTX and REGN?
Savior Lifetec's Total Liabilities of NT$403 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Savior Lifetec and its competitors. Savior Lifetec's current Total Liabilities is NT$403 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Savior Lifetec stock overvalued right now?
Based on GuruFocus' analysis, Savior Lifetec (ROCO:4167) is currently considered Fairly Valued. The stock's GF Value™ is NT$20.31, compared to a current price of NT$21.30 — trading 4.9% above its estimated fair value. The current Total Liabilities is NT$403 Mil. Savior Lifetec's overall GF Score™ is 68/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Savior Lifetec (ROCO:4167), the current Total Liabilities is NT$403 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Savior Lifetec (ROCO:4167) Overvalued in 2026?

Based on GuruFocus' analysis, Savior Lifetec stock appears to be overvalued. The current stock price of NT$21.30 is trading 4.9% above its estimated GF Value™ of NT$20.31. GuruFocus considers Savior Lifetec to be Fairly Valued.

Key valuation signals for ROCO:4167:

  • Total Liabilities: NT$403 Mil
  • GF Value™: NT$20.31 vs. price of NT$21.30 (4.9% above fair value)
  • GF Score™: 68/100 with 3 warning signs

No single metric tells the full story. See the ROCO:4167 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Savior Lifetec Business Description

Address No. 1, Nanke 6th Road, Southern Taiwan Science Park, Sinshih District, Tainan, TWN, 744094
Savior Lifetec Corp is engaged in the research, development, design, manufacture, and sale of carbapenem generics, injection generics, controlled-release generics, development of new dosage forms and drugs, and the APIs, excipients, intermediates, and dosage forms of the aforementioned products. The company also provides medicine manufacturer technology and services. The company geographically operates in four regions: the Americas, Asia, Taiwan, and Europe.
68GF Score

Get the complete analysis for ROCO:4167

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$21.30
Price
NT$20.31
GF Value